So they were wrong yet again. Or they lied in order to get people to take the vaccine. Either one.
Mild cases of COVID-19 leave people with long-term antibody protection against reinfection, according to a new study that challenges previous findings.
“Last fall, there were reports that antibodies wane quickly after infection with the virus that causes COVID-19, and mainstream media interpreted that to mean that immunity was not long-lived,” said study senior author Ali Ellebedy, an associate professor of pathology and immunology, medicine and molecular microbiology at Washington University School of Medicine in St. Louis.
“But that’s a misinterpretation of the data. It’s normal for antibody levels to go down after acute infection, but they don’t go down to zero; they plateau,” Ellebedy said in a university news release. “Here, we found antibody-producing cells in people 11 months after first symptoms. These cells will live and produce antibodies for the rest of people’s lives. That’s strong evidence for long-lasting immunity.”
- Video: Brett Favre BLASTS Woke Sports
- Insane Vid — Man Stream Admission he Killed His Ex-Girlfriend as he prepares to Kill Ex-Wife
- After Mexico City introduced ivermectin plan, COVID hospitalizations and deaths disappeared
- Some French Don’t Surrender! French Mayors Rebel, Will Not Enforce Vaccine Passport at Cafes
- Big–NY judge Grants TRO so State of NY can’t force health care workers to get the VAX
- French National Assembly Passes Anti-Extremism Bill Proposing Stricter Rules for Religion
- 19-year-old Simone Scott was excited for her second dose of #Covid vaccine. Now, Her Mother is Arranging Her Funeral.
- Not so fast. The Very Misleading Article By a Priest on Drugs And Abortion Testing
- The Story you need to know –FDA Buries Data on Seriously Injured Child in Pfizer’s Covid-19 Clinical Trial
- Vid: High school student arrested for defying mask mandate